Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1975 Sep 1;233(9):955-7.
doi: 10.1001/jama.233.9.955.

Portal diversion. Treatment for glycogen storage disease and hyperlipemia

T E Starzl, C W Putnam

Portal diversion. Treatment for glycogen storage disease and hyperlipemia

T E Starzl et al. JAMA. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Coronary arteriogram 16 months after portacaval shunt. Diffuse narrowing of coronary arteries seen in preoperative study had resolved except for three discrete areas of occlusive disease; note one (arrow).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Starzl TE, Marchioro TL, Sexton AW, et al. The effect of portacaval transposition on carbohydrate metabolism: Experimental and clinical observations. Surgery. 1965;57:687–697. - PMC - PubMed
    1. Child CG, Barr D, Holswade GR, et al. Liver regeneration following portacaval transposition in dogs. Ann surg. 1953;138:600–608. - PMC - PubMed
    1. Riddell AG, Davies RP, Clark AD. Portacaval transposition in the treatment of glycogen-storage disease. Lancet. 1966;2:1146–1148. - PubMed
    1. Starzl TE, Putnam CW, Porter KA, et al. Portal diversion for the treatment of glycogen storage disease. Ann surg. 1973;178:525–539. - PMC - PubMed
    1. Starzl TE, Brown BI, Blanchard H, et al. Portal diversion in glycogen storage disease. Surgery. 1969;65:504–506. - PMC - PubMed

Publication types

MeSH terms